3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Recurrence
4
Leukemia, Lymphocytic, Chronic, B-Cell
3
Neoplasm Metastasis
2
Leukemia, Myeloid, Acute
2
Colorectal Neoplasms
2
Waldenstrom Macroglobulinemia
1
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms, Neuroepithelial
1
Nasopharyngeal Carcinoma
1
Myelodysplastic Syndromes
1
Multiple Acyl Coenzyme A Dehydrogenase Deficiency
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Leukemia
1
Hodgkin Disease
1
Head and Neck Neoplasms
1
Glioma
1
Glioblastoma
1
Epstein-Barr Virus Infections
1
Diffuse Intrinsic Pontine Glioma
1
Interventions
Temozolomide
2
Verteporfin
1
Valproic Acid
1
Interleukin-12
1
Aminolevulinic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Neoplasms, Neuroepithelial
×
Valproic Acid
×
Clear all
NCT03243461
2022-06-06
HIT-HGG-2013
University of Göttingen
Phase 3
Unknown
167 enrolled